The initial aim of this study was an in‐depth characterisation of the motoric phenotype seen in CYP2C19 humanised transgenic mice, whereas the subsequent aim was to examine its potential validity as an animal model for cerebellar ataxia. The gene discussed is CYP2C19; the disease is aceruloplasminemia.